Indian Emulsifiers Limited sets ₹49.50 crore rights issue

Indian Emulsifiers Limited has set a ₹49.50 crore rights issue of 1,83,33,222 equity shares at ₹27 each, with eligible shareholders entitled to one rights share for every share held on the October 27, 2026 record date. The issue opens on November 16 and closes on December 1, 2026.

What are the terms of Indian Emulsifiers' 2026 rights issue?

Indian Emulsifiers Limited, referred to hereafter as Indian Emulsifiers, will issue fully paid-up equity shares through a rights issue at a fixed price of ₹27 per share. The price consists of a ₹10 face value and a ₹17 securities premium. The company has proposed 1,83,33,222 rights equity shares, aggregating to ₹49,49,96,994, or about ₹49.50 crore.

The entitlement ratio is 1:1, meaning eligible shareholders will receive the right to apply for one new share for every one share held on the record date of October 27, 2026. The full ₹27 issue price is payable at the time an application is made. There are no partly paid shares under the stated terms.

When can shareholders apply for the Indian Emulsifiers rights issue?

Indian Emulsifiers' rights issue will open on Monday, November 16, 2026, and close on Tuesday, December 1, 2026. Rights entitlements are scheduled to be credited to eligible shareholders by October 29, 2026, before the subscription window begins.

Holders who do not intend to use their entitlement can sell or renounce it on the market until Wednesday, November 25, 2026. This date is the last date for on-market renunciation of rights entitlements. Shareholders considering participation or renunciation must act within the stated market and issue timelines.

The company has indicated that the basis of allotment will be finalised and shares will be allotted on or about December 2, 2026. The new shares are expected to be credited to successful applicants' demat accounts and listed on NSE SME on or about December 3, 2026.

Why is Indian Emulsifiers raising funds through rights shares?

Indian Emulsifiers plans to use the proceeds to invest in its US subsidiary, Polaris Specialty Chemicals Inc. The company has also identified the purchase of shares of Chemical Brothers Enterprises Pvt Ltd as a use of the issue proceeds.

Other stated uses include working-capital funding and general corporate purposes. The disclosures do not provide a separate allocation for each proposed use. The issue therefore gives investors the overall purposes identified by the company, without a break-up of the ₹49.50 crore across those purposes.

The board had earlier approved an equity rights issue of up to ₹51 crore on May 16, 2026. After receiving in-principle approval from the National Stock Exchange, the rights issue committee met on October 21 to determine the final price, entitlement ratio, record date, payment mechanism and timetable. The eventual issue size is below the previously approved maximum amount.

How does this issue compare with Indian Emulsifiers' earlier rights offer?

Indian Emulsifiers completed an earlier rights issue in 2025 at a substantially different price and ratio. That issue offered one equity share for every two shares held at ₹80 per share, including a ₹70 premium on a ₹10 face value. Its stated issue size was ₹48.89 crore for 61,00,000 shares.

The 2026 offer has a 1:1 entitlement ratio, a ₹27 issue price and a ₹17 premium. It also involves 1,83,33,222 shares, far more than the 61,00,000 shares disclosed for the 2025 offer. The current issue's aggregate size of about ₹49.50 crore is broadly close to the earlier issue size, while its pricing and number of shares differ.

For shareholders, the immediate operational point is the entitlement process. Eligible holders receive rights entitlements that can be used to apply, or sold on the market by the renunciation deadline. Investors should distinguish the rights entitlement from the new equity share, which will be issued only following the allotment process.

What does the rights issue mean for shareholders and the company?

The rights issue provides Indian Emulsifiers with a defined route to seek equity capital from existing shareholders before the company funds the disclosed investment, acquisition, working-capital and corporate requirements. The full application payment requirement means applicants must pay ₹27 for every rights share they seek to subscribe to at application.

The transaction is also relevant to trading in rights entitlements during the available renunciation period. The entitlements are scheduled for credit by October 29, and their last on-market trading date is November 25. The company has separately stated that the new shares are expected to list on NSE SME on or about December 3, subject to the stated allotment timetable.

Conclusion

Indian Emulsifiers has finalised a 1:1 rights issue priced at ₹27 per share, seeking about ₹49.50 crore through 1,83,33,222 fully paid-up shares. The company has identified investment in Polaris Specialty Chemicals Inc, purchase of shares in Chemical Brothers Enterprises Pvt Ltd, working capital and general corporate purposes as the intended uses of the funds.

The next disclosed milestones are the November 16 opening, November 25 deadline for on-market renunciation and December 1 closing date. Investors will then watch the basis of allotment, scheduled on or about December 2, followed by the expected demat credit and NSE SME listing of the new shares on or about December 3.